Missing the mark on prostate-specific antigen screening.
Department of Urology and Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, MI 48109, USA. dcmiller@umich.edu
David C
DC
Miller
Brent K
BK
Hollenbeck
D026683:Advisory Committees; D000367:Age Factors; D000368:Aged; D001706:Biopsy / Q000009:adverse effects; D003657:Decision Making; D017408:Guidelines as Topic; D006291:Health Policy; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000592:standards*; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000175:diagnosis* / Q000401:mortality; D016019:Survival Analysis; D014481:United States; D019564:Unnecessary Procedures
D017430:Prostate-Specific Antigen